Development of a companion diagnostic to identify patients who respond to microbiome-targeting drugs
Ended Project Grant Awarded Last action
- Award ID
- R44GM128477
- Recipient
-
Symberix, Inc. UEI HN72U2V5AKN7
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,424,310
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Funding
-
- $2,577,595.00 Federal
- $846,715.00 Non-federal
- Place of performance
- Durham, NC 27703, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $846,715 | $0 | |
| Amendment | $846,715 | $846,715 | |
| Original award | $884,165 | $0 |
Quick answers
Who received award R44GM128477?
R44GM128477 was awarded to Symberix, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on April 1, 2018.
How much is award R44GM128477 worth?
$3,424,310 has been obligated on R44GM128477: $2,577,595 in federal funding and $846,715 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award